Company Filing History:
Years Active: 2019-2025
Title: Julie L. Berry: Innovator in Surgical Instrument Control
Introduction
Julie L. Berry is a prominent inventor based in San Jose, California, known for her significant contributions to the field of surgical technology. With a total of 12 patents to her name, she has made remarkable advancements in the control of surgical instruments, enhancing the precision and effectiveness of surgical procedures.
Latest Patents
Among her latest patents is a "System and method for patient-side instrument control." This innovative system includes a first actuator for controlling a mechanical degree of freedom and a second actuator for another degree of freedom. The controller is designed to maintain the first actuator at a specified position while adhering to torque limits. It also intelligently terminates commands to the first actuator if it cannot maintain its position, ensuring optimal performance during surgical operations. Another notable patent is for "Teleoperated surgical system equipment with user interface." This method involves operably coupling a surgical instrument to a flux supply unit and altering the graphical user interface based on the connection, thereby improving user interaction and efficiency.
Career Highlights
Julie L. Berry is currently employed at Intuitive Surgical Operations, Inc., a leading company in the development of robotic surgical systems. Her work has been instrumental in advancing the capabilities of surgical instruments, making procedures safer and more efficient.
Collaborations
Throughout her career, Julie has collaborated with talented individuals such as Paul W. Mohr and Brandon D. Itkowitz. These partnerships have fostered innovation and contributed to the success of her projects.
Conclusion
Julie L. Berry's contributions to surgical technology through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to influence the future of surgical procedures, making them more precise and effective.